Arturo Molina - Jan 12, 2022 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role
Director
Signature
/s/ Jeannette Potts, as Attorney-in-Fact
Stock symbol
FMTX
Transactions as of
Jan 12, 2022
Transactions value $
$0
Form type
4
Date filed
1/13/2022, 03:22 PM
Previous filing
Sep 28, 2021
Next filing
Feb 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FMTX Common Stock Award $0 +5.5K $0.00 5.5K Jan 12, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FMTX Stock Option (Right to Buy) Award $0 +16.8K $0.00 16.8K Jan 12, 2022 Common Stock 16.8K $11.97 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
F2 33.3% of the shares subject to the stock option will vest on January 12, 2023, and the remainder of the shares vest in equal monthly installments for a period of 24 months thereafter.